Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Lifecare AS ( (DE:LFC0) ) is now available.
Lifecare ASA announced the commencement of the exercise period for 4,193,806 warrants related to a rights issue of new shares completed in June 2024. Each warrant allows the holder to subscribe for a new share at a specified price, with the exercise period ending on June 13, 2025. Warrants not exercised or sold by the deadline will become valueless, potentially diluting the shareholding of those who do not act. This announcement could impact Lifecare’s market positioning by influencing shareholder decisions and the company’s capital structure.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes. The company aims to bring the next generation of Continuous Glucose Monitoring (CGM) systems to market, utilizing osmotic pressure as a sensing principle. Lifecare’s sensor technology is designed to identify and monitor a wide range of analytes and molecules in both humans and pets.
Average Trading Volume: 39,494
Current Market Cap: NOK98.61M
For detailed information about LFC0 stock, go to TipRanks’ Stock Analysis page.